Inventor
WIDDOWSON KATHERINE LOUISA
US17 patents
⚠️ This page may combine multiple inventors who share the name “WIDDOWSON KATHERINE LOUISA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SMITHKLINE BEECHAM CORP
9 patentsUS5780483AJul 14, 1998
IL-8 receptor antagonists
SMITHKLINE BEECHAM CORP186 citations98
US6262113B1Jul 17, 2001
IL-8 receptor antagonists
SMITHKLINE BEECHAM CORP118 citations97
US6005008ADec 21, 1999
IL-8 receptor antagonists
SMITHKLINE BEECHAM CORP118 citations97
US5886044AMar 23, 1999
IL-8 receptor antagonists
SMITHKLINE BEECHAM CORP171 citations96
US6180675B1Jan 30, 2001
IL-8 receptor antagonists
SMITHKLINE BEECHAM CORP78 citations95
US6211373B1Apr 3, 2001
Phenyl urea antagonists of the IL-8 receptor
SMITHKLINE BEECHAM CORP58 citations92
US6767922B2Jul 27, 2004
IL-8 receptor antagonists
SMITHKLINE BEECHAM CORP13 citations84
US6664259B2Dec 16, 2003
Il-8 receptor antagonists
SMITHKLINE BEECHAM CORP15 citations84
US6608077B2Aug 19, 2003
Il-8 receptor antagonists
SMITHKLINE BEECHAM CORP17 citations84
GLAXOSMITHKLINE IP DEV LTD
7 patentsUS11697665B2Jul 11, 2023
C-mannoside compounds useful for the treatment of urinary tract infections
GLAXOSMITHKLINE IP DEV LTD3 citations70
US11111262B2Sep 7, 2021
C-mannoside compounds useful for the treatment of urinary tract infections
GLAXOSMITHKLINE IP DEV LTD1 citations70
US11229646B2Jan 25, 2022
Method for treating gonorrhea with (2R)-2-({4-[(3,4-dihydro-2H-pyrano[2,3-C]pyridin-6-ylmethyl)amino]-1-piperidinyl}methyl)-1,2-dihydro-3H,8H-2A,5,8A-triazaacenaphthylene-3,8-dione
GLAXOSMITHKLINE IP DEV LTD1 citations62
US10702521B2Jul 7, 2020
Methods for treating neisseria gonorrhoeae infection with substituted 1,2-dihydro-2A,5,8A-triazaacenaphthylene-3,8-diones
GLAXOSMITHKLINE IP DEV LTD1 citations62
US12552824B2Feb 17, 2026
C-mannoside compounds useful for the treatment of urinary tract infections
GLAXOSMITHKLINE IP DEV LTD0 citations59
US12351597B2Jul 8, 2025
Substituted biphenyl or phenylheteroaryl-mannosides as antagonists of FimH
GLAXOSMITHKLINE IP DEV LTD0 citations59
US12297223B2May 13, 2025
Compounds
GLAXOSMITHKLINE IP DEV LTD0 citations48